2 results match your criteria: "Capital Medical University Affiliated Youan Hospital[Affiliation]"
Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis.
Biomed Res Int
January 2021
Department of General Surgery and Liver Transplantation Center, Capital Medical University Affiliated Youan Hospital, Beijing 100069, China.
Background: Circulating microRNA-122 (miR-122) has been recognized as a marker of hepatocellular carcinoma (HCC). The current meta-analysis was performed to quantitatively evaluate the diagnostic performance of circulating miR-122 for HCC.
Methods: Related studies that evaluated the diagnostic performance of circulating miR-122 determined from pathophysiological examination for HCC were obtained by systematic searches of the PubMed and Embase databases.
Curcumin protects against hepatic ischemia/reperfusion induced injury through inhibiting TLR4/NF-κB pathway.
Oncotarget
September 2017
Department of Surgery and Liver Transplantation Center, Capital Medical University Affiliated Youan Hospital, Beijing, China.
The TLR4/NF-κB pathway had important roles in hepatic ischemia/reperfusion (I/R) injury. In this study, we reported a protective effect of curcumin against hepatic I/R injury via TLR4/NF-κB pathway. Curcumin significantly inhibited cell apoptosis, and decreased levels of LDH and production of TNF-a, IL-1b, and IL-6 in the cell supernatant.
View Article and Find Full Text PDF